Double-blind, placebo-controlled trial on the effect of piracetam on breath-holding spells
Breath-holding spells (BHS) are apparently frightening events occurring in otherwise healthy children. The aim of this study was to evaluate the efficacy of piracetam in the treatment of breath-holding spells. Forty patients with BHS (who were classified into two groups) were involved in a double-blinded placebo-controlled prospective study. Piracetam was given to group A while group B received placebo. Patients were followed monthly for a total period of 4 months. The numbers of attacks/month before and monthly after treatment were documented, and the overall number of attacks/month after treatment was calculated in both groups. The median number of attacks/month before treatment in the two groups was 5.5 and 5, respectively, while after the first month of treatment, it was 2 and 5, respectively. The median overall number of attacks/month after treatment in both groups was 1 and 5, respectively. There was a significant decline of number of attacks after piracetam treatment compared to placebo (p value < 0.001). There were no reported side effects of the piracetam throughout the study period. In conclusion, piracetam is a safe and effective drug for the treatment of breath-holding spells in children.
KeywordsPiracetam Breath-holding spells Pallid spells Cyanotic spells
Conflict of interest
The authors declare that they have no conflict of interest.
- 5.DeMyer W (2005) Breath holding spells. In: Maria BL (ed) Current management of child neurology, 3rd edn. BC Decker Inc, Hamilton, pp 353–355Google Scholar
- 13.Winnicka K, Tomasiak M, Bielawska A (2005) Piracetam-an old drug with novel properties. Acta Poloniae Pharmaceutica-Drug Research 62(5):405–409Google Scholar